Back to search

Article

Phase II Feasibility Study of Adjuvant Chemotherapy With Docetaxel/Cisplatin/S-1 Followed By S-1 For Stage III Gastric Cancer

2021-06-02

Abstract excerpt

<h4>Background: </h4> To evaluate the feasibility, safety, and efficacy of postoperative adjuvant chemotherapy with docetaxel/cisplatin/S-1 (DCS) following S-1 therapy in patients with stage III gastric cancer after curative gastrectomy. <h4>Methods: </h4> Patients with stage III gastric cancer who underwent D2 gastrectomy were enrolled. Adjuvant chemotherapy was initiated within 8 weeks of gastrectomy. The first...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3d016109-106c-50bf-b5d4-454973e85200
DOI
10.21203/rs.3.rs-530127/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Phase II Feasibility Study of Adjuvant Chemotherapy With Docetaxel/Cisplatin/S-1 Followed By S-1 For Stage III Gastric CancerDOI 10.21203/rs.3.rs-530127/v1
Select a neighboring publication to make it the new centre.